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1. Introduction
Postpartum psychiatric disorders have traditionally been clas
sified as baby blues, postpartum depression (PPD), and puerp
eral psychosis. The baby blues is not a psychiatric illness but
rather a constellation of transitory symptoms for which no
treatment is required. Similarly, puerperal psychosis is
a misnomer because it is generally a mood episode with
psychotic features in women with bipolar disorder [1].
Postpartum depression is commonly defined as occurrence
of a major depressive episode in the first few weeks after
delivery although some women experience onset of symp
toms during pregnancy. Affecting approximately 14% of
women within the first 4–6 weeks of delivery [2], PPD is one
of the most common medical complications of childbirth.
Untreated or inappropriately treated PPD is associated with
multiple adverse maternal and infant outcomes [3]. Thus,
correct diagnosis in a timely manner is critically important
for optimal treatment of women with depression and related
disorders. The term PPD has been in use for half a century
both as lay term and a diagnostic entity. Due to the increased
public awareness of depression in the postpartum period and
consequently reduced stigma, women are more likely to
undergo screening and seek professional help [4]. For some
women, a diagnosis of PPD may be more acceptable than
a diagnosis of a mood disorder due to the purported role of
hormonal imbalance in the former.
In this Editorial, the limitations of using PPD as a diagnostic
category are discussed. It is argued that due to its limited
diagnostic and therapeutic utility, preference should be
given to more specific terminology to capture the heteroge
neity of depression in the postpartum period.

and Lactating Women published in 1858, Louis-Victor Marcé
first provided a systematic account of psychiatric illness during
and after pregnancy [7]. He argued that PPD should be
accorded a distinct diagnostic status even though most symp
toms of the syndrome could be found in cases of nonperperperal depression.
With the advent of antidepressant drugs in the 1950s, there
was renewed interest in the nosology of PPD, particularly
among women who were not ‘ill enough to be admitted to
hospital’ [8]. In a seminal paper published in 1968, Bryce Pitt
suggested that PPD should be viewed on a continuum
between severe puerperal depression on the one hand and
the commonly occurring baby blues on the other. He found
that a large number of cases of PPD were characterized by
‘atypical’ symptoms, such as anxiety, phobias, and irritability or
had symptoms that were the opposite of classical depression,
e.g. reversed diurnality and early rather than late insomnia.
According to Pitt, the atypical depression is more likely to be
encountered in outpatient settings compared to the ‘severe
puerperal depression.’ Over time, Pitt’s severity-based classifi
cation was neglected and the atypical variant per se became
symbolic of PPD. With the publication of its fourth edition in
1996, the DSM first acknowledged that PPD can also occur as
an episode of bipolar I disorder. The DSM-5 expanded the
scope of the specifier to characterize cases of bipolar II depres
sion. And for the first time the specifier could be used for
mood episodes occurring during pregnancy. In spite of the
‘official’ recognition that a postpartum depressive episode can
occur as part of major depressive disorder or bipolar disorder,
the term PPD does not make a distinction between the two
main subtypes of depression in the postpartum period.

2. Evolution of the concept

3. Comorbidities and associated features

Whether or not PPD is a distinct illness has been debated for
more than 150 years [5]. Jean-Etienne Esquirol was one of the
first physicians to provide descriptions of postpartum mental
illness among women admitted to Salpêtrière Hospital in Paris
[6]. Esquirol was of the opinion that the prevalence of puerp
eral mental illness was much greater in the community than
the data from mental hospitals would indicate. In his influen
tial monograph Treatise on Insanity in Pregnant, Postpartum,

There is emerging evidence that major depressive disorder is
just one of several psychiatric disorders triggered by child
birth. Hypo/manic symptoms are common in the postpartum
period and can occur as part of bipolar disorder or major
depressive disorder with mixed features. Subthreshold epi
sodes of hypomania are ubiquitous after delivery and are
associated with increased risk of depression in the postpartum
period [9].
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Postpartum depression is invariably accompanied by
anxiety and related disorders including generalized anxiety
disorder, panic disorder, obsessive-compulsive disorder and
post-traumatic stress disorder. There is emerging evidence
that women may be at a particularly increased risk of first
onset or recurrence of obsessive-compulsive disorder in the
postpartum period [10]. A fear of having or acquiring grave
physical illness as in illness anxiety disorder also appears
common; however, women are reluctant to share physical
health concerns in psychiatric settings. Unusual irritability is
common but often neglected. Singular focus on depression
may affect the identification and diagnosis of its common
comorbidities.

4. Diagnostic and treatment implications
A diagnosis of PPD is generally based on a cross-sectional
assessment of symptoms. A postpartum episode can be
the first occurrence of depression, but the majority of
women have a history of depression. First onset of depres
sion after delivery is associated with increased risk of
future hypo/manic episodes. Awareness of clinical features,
such as timing of episode onset vis-à-vis delivery (preg
nancy vs. postpartum), type of onset (rapid vs. gradual),
polarity [11], and type of symptoms (typical vs. atypical) is
important for diagnostic and treatment purposes [12].
Equally important is an understanding of the longitudinal
illness course.
Due to increased awareness of PPD, women are commonly
screened and assessed for depression but not for other com
monly occurring psychiatric disorders. The Edinburgh
Postnatal Depression Scale (EPDS) – perhaps the most com
monly used screening instrument for PPD – has three items to
screen for anxiety. However, the EPDS may not reliably dis
criminate between depression and anxiety. In spite of their
common occurrence and associated emotional distress and
disability, women are generally not screened or assessed for
co-morbid psychiatric disorders.
Failure to screen for hypo/mania may lead to misdiagno
sis of bipolar disorder as major depressive disorder. Use of
antidepressants in these patients may induce hypo/mania
and increase risk of self-harm and psychiatric hospitaliza
tion. A population-based cohort study from Denmark found
a previous diagnosis of bipolar disorder was the strongest
predictor of rehospitalization 10–19 days postpartum. In
total approximately 27% of women with this diagnosis
required
rehospitalisation
within
the
first
postpartum year [13].

5. Reconceptualization of postpartum depression
In light of its limited clinical utility, the term PPD should be
abandoned in favor of more specific terminology, such as
major depressive disorder or bipolar disorder with peripar
tum onset. In addition to clarifying the polarity, the appli
cation of DSM-5 specifiers, such as peripartum onset,
anxious distress, or mixed features should provide clinically
useful characterization of the index depressive episode.
Positioning PPD in the context of an existing or developing

mood disorder is similar to the approach used for physical
illnesses with high risk of postpartum recurrence. For
example, we do not use the term postpartum multiple
sclerosis even though up to 30% of women with multiple
sclerosis have a postpartum recurrence. In other instances,
a specific term (such as gestational diabetes) is used when
a woman without past history develops the disease for the
first time during pregnancy.
The recommended approach should facilitate rigorous fol
low-up of women who are at risk of having postpartum
occurrence of depression due to the personal history of
depression, anxiety disorders or obsessive-compulsive disor
der. Since more than half of women with PPD have prepartum
onset, early intervention during pregnancy may attenuate or
prevent depression in the postpartum period. A similar
approach could be taken in the care of primiparous women
who are at risk of developing depression due to the history of
mood disorders in first-degree relatives. Prospective monitor
ing of at-risk women should allow for easier identification of
hypomanic symptoms that closely follow delivery.
Reconceptualizing PPD as an episode of major depressive
disorder or bipolar disorder would prompt clinicians to carry
out comprehensive assessment to clarify the diagnosis before
embarking upon treatment. Diagnosing PPD using the diag
nostic criteria should also facilitate studies on the impact of
maternal depression on infant attachment [14]. Use of safe
and disorder-specific treatments could improve the outcome
of depression. Antidepressants are the mainstay of drug treat
ment of unipolar PPD and are recommended for moderate to
severe PPD, or for women who fail to respond to or refuse
psychological interventions. However, two systematic reviews
concluded that there is insufficient evidence from clinical trials
to recommend treatment with antidepressants. It is possible
that failure to exclude women with bipolar disorder (particu
larly those with bipolar II or other specified bipolar and related
disorder) may have affected the results of these studies. In
contrast to the substantial literature (six open-label studies
and nine randomized controlled trials of antidepressants) on
the drug treatment of unipolar PPD, the literature on bipolar
PPD is sparse and consists of only two open trials of quetia
pine [15,16].
In conclusion, it is proposed that episodes of depression
that are now subsumed under the PPD umbrella should be
repositioned within the existing DSM classification framework
for mood disorders. Although there might be some benefit in
retaining the term for lay descriptions or explanations (e.g.
treatment seeking, stigma reduction), there would be greater
benefit to clinical practice and research if such episodes were
classified within the current framework for episodes of mood
disorders.
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